60 related articles for article (PubMed ID: 31229797)
41. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1
Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ
Molecules; 2023 May; 28(9):. PubMed ID: 37175382
[TBL] [Abstract][Full Text] [Related]
42. Small molecule compounds with good anti-inflammatory activity reported in the literature from 01/2009 to 05/2021: a review.
Bian M; Ma QQ; Wu Y; Du HH; Guo-Hua G
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2139-2159. PubMed ID: 34628990
[TBL] [Abstract][Full Text] [Related]
43. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.
Kerru N; Gummidi L; Maddila S; Gangu KK; Jonnalagadda SB
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326131
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
[TBL] [Abstract][Full Text] [Related]
45. Pyrazoles containing thiophene, thienopyrimidine and thienotriazolopyrimidine as COX-2 selective inhibitors: Design, synthesis, in vivo anti-inflammatory activity, docking and in silico chemo-informatic studies.
El-Shoukrofy MS; Abd El Razik HA; AboulWafa OM; Bayad AE; El-Ashmawy IM
Bioorg Chem; 2019 Apr; 85():541-557. PubMed ID: 30807897
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents.
Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
[TBL] [Abstract][Full Text] [Related]
49. Contemporary advances of cyclic molecules proposed for inflammation.
Neha K; Wakode S
Eur J Med Chem; 2021 Oct; 221():113493. PubMed ID: 34029774
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797
[TBL] [Abstract][Full Text] [Related]
51. Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.
Kaur R; Chaudhary S; Kumar K; Gupta MK; Rawal RK
Eur J Med Chem; 2017 May; 132():108-134. PubMed ID: 28342939
[TBL] [Abstract][Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
